Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04)

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

(2012) R. Coleman et al.   ANNALS OF ONCOLOGY

Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases

(2011) F. Saad et al.   ANNALS OF ONCOLOGY

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

(2011) A. M. Vandone et al.   ANNALS OF ONCOLOGY

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer

(2011) R. Coleman et al.   BREAST CANCER RESEARCH AND TREATMENT

Final 5-year results of Z-FAST trial

(2011) Adam M. Brufsky et al.   CANCER

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

(2011) Michael Gnant et al.   LANCET ONCOLOGY

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

(2011) Robert E. Coleman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality of Life Implications of Bisphosphonate-Associated Osteonecrosis of the Jaw

(2011) R. A. Miksad et al.   ONCOLOGIST

Zoledronic acid

(2010) Robert Coleman et al.   Expert Opinion On Drug Safety

Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review

(2010) Cesar A. Migliorati et al.   Nature Reviews Endocrinology

Impact of oral disease on quality of life in the US and Australian populations

(2009) Anne E. Sanders et al.   COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY

Editorial Board

(2009)   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid

(2008) M. A. Dimopoulos et al.   ANNALS OF ONCOLOGY

Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan

(2008) C. I. Ripamonti et al.   ANNALS OF ONCOLOGY

Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with Zoledronate

(2008) Christian Walter et al.   EUROPEAN UROLOGY